Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. - Wikidata - awgldk - TriplyDB

Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.

Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.

http://www.wikidata.org/entity/Q44548364

about

Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia A Dormant Microbial Component in the Development of Preeclampsia Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia.Treating the dysfunctional placenta.Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).Preeclampsia and Pregnancy-Related Hypertensive Disorders Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.Potential targets for the treatment of preeclampsia.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?Upcoming drugs for the treatment of preeclampsia in pregnant women.Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.Decitabine Improves the Clinical Manifestations of Rats With l-NAME-Induced Pre-eclampsia: A Potential Approach to Studying Pre-eclampsia.Optimal first trimester preeclampsia prediction: a comparison of multimarker algorithm, risk profiles and their sequential application.Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.Molecular Mechanisms of Preeclampsia.Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms.

P2860

Q26849333-9BCCFCDA-E603-4EC3-982B-30A74E89F523 Q28069689-BD1852C1-F83D-4636-B5F2-D9E39BD43A7A Q28083815-1467B5CF-DA22-4062-8E40-3B3BC72F60FB Q30833322-6BF854DB-C66C-478B-8128-3C2F7B65909A Q33639463-6FF94B66-097D-4DEB-B0CB-593C49AF6ACB Q33668328-1194C9D0-F406-4A4D-BCE0-C716C44D5880 Q33917113-30854574-DA47-4B7D-B1B8-D559AA1CFCAC Q34937179-6EF977AD-F6E8-4060-AF16-B3E4D9D096DD Q35813932-381B909F-F4F0-4071-B188-D77C73CCA372 Q36281300-8D9FC170-C6EC-40A8-88EB-31C22F5C0E4B Q36455584-AB0E0F36-9760-4298-9C81-2102B08A7714 Q36584747-B9FB8039-5CCA-458B-8D22-C2C8182F1C07 Q36901534-F08DE86E-ABD2-42D8-A269-5DAE8A979B8C Q36945433-61DCCF47-31A2-43DF-A5A3-F1941A6DDF54 Q36978198-9ADBFF74-53AD-4EDE-BB21-0C6E96B708AA Q38590180-0D6B4CB2-79B5-4736-8358-7798F150B8C4 Q38592484-6B0A743D-1F3C-415E-AF15-5E3C4CE658A5 Q39139549-F0F1359D-688A-48A2-B4AF-E6A1B866984B Q39152873-A9EB736F-0BE8-4EEA-9528-85C2D0926AA9 Q39773129-8AC404DD-EB5E-4735-82B9-5A22FE6ACC0E Q40521260-0C6405C8-CF96-453F-AB43-F5299F1B93AB Q42394216-7B954C64-34FA-4090-9F9E-01ACB12D6B0C Q46311114-3113386E-CE97-4002-9F6C-FA2674A3E462 Q48122441-EDBFC025-50A7-4284-B9E9-009290BA1391 Q48268967-93CEEE7E-D936-4AAA-91DC-46A2E6D12F02 Q49212311-2C42912E-2A7D-4722-97D7-7108B2A111A7 Q54901493-356F4106-6B72-4E51-AF54-01C3F3C5ABD5 Q55021608-391C9000-4953-4187-84B7-975E70C11EC5

P2860

Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.

http://www.wikidata.org/entity/Q44548364

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@en

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@nl

type

label

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@en

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@nl

prefLabel

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@en

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@nl

P1433

Q44548364-A0577F45-6D64-4058-9135-D3F43A8EA4DE

P1476

Q44548364-0A85475E-4452-4B2C-9417-6CC6D709FF92

P2093

Q44548364-1DA66E1C-3481-453B-B177-03BA63C4F95F

Q44548364-4ED77E59-45A3-4828-A10D-AC18CA0925DA

Q44548364-566C1032-FCC2-4DD6-BC25-9E70A6D96EE1

Q44548364-74F3AF32-DA00-4B0A-92CF-A166C38422A8

Q44548364-82052E10-E2EA-4D04-B5B3-C6DF28C61B2F

Q44548364-BC90037D-80F8-4AF2-B887-07604203E6B2

Q44548364-C5B0DCF0-8B7A-41A8-9B59-B9965EDC278D

Q44548364-CAEEE29C-5745-45B8-8D10-CD7934061CC8

Q44548364-CC888B2D-5F59-4245-BAB1-5589C718DAC0

Q44548364-E18D08DE-B74A-492A-9EDE-04CF80B1A75A

P2860

Q44548364-030BFD93-F63C-41BF-97CC-64DD21DFC9C7

Q44548364-05F17961-B814-418B-B842-AAEF8A670CB5

Q44548364-07EF7D95-987E-479E-85F9-AAA75236EBC0

Q44548364-19E52B99-AD3B-47CF-8D58-E32948ADE47E

Q44548364-21878112-BB0F-410E-AB9F-359443EA92F4

Q44548364-249B73AD-A439-4AB8-9483-23A917ABB0B6

Q44548364-259850A2-8BD5-4BC3-A18D-8A7716BCE75A

Q44548364-316CE93D-8B6C-441D-BA28-B21421FC48DD

Q44548364-3BC6B52A-B93F-42BB-9A34-552389385D30

Q44548364-41A05D8C-49EC-4A01-8D28-4B37A8F219B2

P304

Q44548364-DAB81656-7289-4454-BA6F-3117417A144F

P31

Q44548364-16329951-089C-41A2-8990-ED75297F428D

P356

Q44548364-2F7C3307-6106-426F-9337-4049116A7348

P433

Q44548364-7C672F31-2CC2-4032-8735-604D130CFF2F

P478

Q44548364-D686BB9E-366B-47B3-9927-F936EBEE659F

P577

Q44548364-72B6CD93-826D-4753-AAD0-9ECEC4B0F8F0

P698

Q44548364-E57217F5-B53E-4EB8-BFBB-9632E867933E

P921

Q44548364-14CBC741-4D5F-4611-986A-627F9C08FCE8

Q44548364-4FB265A1-2E51-4FE4-A42A-7DAFB0DB6A01

P356

1933719113492207

P1433

Reproductive Sciences

P1476

Effects of pravastatin on angi ...... a mouse model of preeclampsia.

@en

P2093

Antonio F Saad

http://www.w3.org/2001/XMLSchema#string

Elena Sbrana

http://www.w3.org/2001/XMLSchema#string

Esther Tamayo

http://www.w3.org/2001/XMLSchema#string

Gary D V Hankins

http://www.w3.org/2001/XMLSchema#string

George R Saade

http://www.w3.org/2001/XMLSchema#string

Huaizhi Yin

http://www.w3.org/2001/XMLSchema#string

Maged M Costantine

http://www.w3.org/2001/XMLSchema#string

Michael Wen

http://www.w3.org/2001/XMLSchema#string

Monica Longo

http://www.w3.org/2001/XMLSchema#string

Talar Kechichian

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia

Inflammation, atherosclerosis, and coronary artery disease

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Vitamins C and E to prevent complications of pregnancy-associated hypertension

A new mouse model to explore therapies for preeclampsia.

Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

P304

138-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1933719113492207

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23749761

http://www.w3.org/2001/XMLSchema#string

P921